Beleagured x-ray digitization firm Fidelity Medical of Florham Park, NJ, announced that it hasfiled its Form 10-K with the Securities and Exchange Commissionstating its 1994 results. Fidelity had postponed filing the formdue to doubts about the company's
Beleagured x-ray digitization firm Fidelity Medical of Florham Park, NJ, announced that it hasfiled its Form 10-K with the Securities and Exchange Commissionstating its 1994 results. Fidelity had postponed filing the formdue to doubts about the company's future (SCAN 2/1/95). Fidelity'sresults closely matched expectations, with annual net revenuesof $3.5 million and a net loss of $1.9 million. Fidelity saidit is exploring options to sustain continued operations and isnegotiating with an investment bank for a private stock placement.It is also examining a potential acquisition.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.